The list compiled by Alantra, an international financial services company, ranks companies according to their revenue growth over the past two years.

Richmond Pharmacology is delighted with the recognition and features in the lists top twenty at number 17. The Alantra Pharma Fast 50 is in its fifth year and was launched to recognise and celebrate successful business within the UK life sciences market.

The list includes analysis of businesses grouped into four distinct sub-sectors – Technology; Analytics, insights and communication; Pharma outsourcing; and Develop, wholesale and supply.

Richmond Pharmacology is categorised in the publication as a Contract research organisation providing services from design to delivery of early phase clinical trials.

Read the report in full

Latest news

Patient safety is not an afterthought. Explore our new infographic!

September 17, 2025
Patient safety is not an afterthought; it is the foundation of every clinical trial.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event